Mar 20 • 19:21 UTC 🇧🇷 Brazil G1 (PT)

Amapá registers increase in cases of severe acute respiratory syndrome, says Fiocruz

Fiocruz reports a rise in severe acute respiratory syndrome cases in Amapá, Brazil, due to circulating influenza A and other viruses.

In the latest InfoGripe Bulletin by Fiocruz, a notable increase in cases of severe acute respiratory syndrome (SRAG) has been observed in Amapá, a state in northern Brazil. The bulletin indicates that the region is experiencing early seasonal circulation of influenza A, leading to an alert level for SRAG. The analysis covering Epidemiological Week 10, which spans from March 8 to March 14, indicates that not only is the number of cases increasing in Amapá, but the capital city Macapá is also among 18 Brazilian cities seeing this uptick, suggesting a troubling trend that may continue if not addressed.

The report highlights several viruses contributing to this rise in SRAG cases. Rhinovirus, which primarily impacts children and adolescents, has been identified alongside influenza A, which predominantly affects young adults, adults, and the elderly. Furthermore, respiratory syncytial virus (RSV) is noted to significantly impact children under the age of two, indicating a serious threat to some of the most vulnerable groups in the population. This combination of viruses appears to be straining healthcare resources in the region, which might lead to increased hospitalizations if the trend continues.

As Amapá copes with this public health challenge, the implications may stretch beyond the immediate healthcare concerns. Increased vigilance and public health measures will be essential to curb the spread of these viruses, especially as they disproportionately affect certain demographics. With the winter season approaching in Brazil, health authorities are likely to intensify vaccination campaigns and awareness efforts to protect the community from further escalation of SRAG cases, underlining the importance of timely vaccination and public health education in managing respiratory diseases.

📡 Similar Coverage